Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-23
    E.g., 2018-10-23

Archive Search

1 results
12:14 PM, Jun 01, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Avrobio proposes $86.3M NASDAQ IPO

slated to enter a Phase II trial mid-year -- comprises stem cells engineered to express alpha galactosidase